PRIME CAPITAL INVESTMENT ADVISORS, LLC – Gilead Sciences, Inc. Transaction History
PRIME CAPITAL INVESTMENT ADVISORS, LLC portfolio value:
$569,000
portfolio value
PRIME CAPITAL INVESTMENT ADVISORS, LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +183.38% | 5.96K shares | 368K | $61.69 | 9.22K |
| Q2 2022 | share | Increase | 0.00% | 3.25K shares | 201K | $61.81 | 3.25K |
| Q2 2021 | share | Decrease | -100.00% | -929 shares | -60K | $68.17 | 0 |
| Q1 2021 | share | Decrease | -32.04% | -438 shares | -20K | $63.33 | 929 |
| Q4 2020 | share | Decrease | -97.38% | -50.73K shares | -3.21M | $56.43 | 1.36K |
| Q3 2020 | share | Decrease | -18.04% | -11.46K shares | -1.59M | $60.52 | 52.10K |
| Q2 2020 | share | Increase | +5301.36% | 62.39K shares | 4.80M | $72.94 | 63.57K |
| Q1 2020 | share | Increase | +460.48% | 967 shares | 74K | $70.22 | 1.17K |
| Q4 2019 | share | Decrease | -91.24% | -2.18K shares | -138K | $60.43 | 210 |
| Q3 2019 | share | Decrease | -93.19% | -32.81K shares | -2.22M | $58.4 | 2.39K |
| Q2 2019 | share | Decrease | -0.94% | -333 shares | 68K | $61.67 | 35.21K |
| Q1 2019 | share | Decrease | -16.50% | -7.02K shares | -352K | $58.79 | 35.55K |
| Q4 2018 | share | Increase | +2.47% | 1.02K shares | -545K | $56.02 | 42.57K |
| Q3 2018 | share | Increase | +40.21% | 11.91K shares | 1.10M | $68.57 | 41.55K |
| Q2 2018 | share | Increase | +12045.49% | 29.39K shares | 2.08M | $62.43 | 29.63K |
| Q1 2018 | share | Decrease | -99.31% | -35.05K shares | -2.51M | $65.91 | 244 |
| Q4 2017 | share | Increase | 0.00% | 35.3K shares | 2.52M | $62.19 | 35.3K |